Submitted:
16 October 2023
Posted:
19 October 2023
You are already at the latest version
Abstract
Keywords:
1. Materials and Methods
1.1. Participants and Grouping
1.2. Disease Diagnostic Criteria
1.3. Outcome Measures
1.4. Statistical Analysis
2. Results
2.1. Patient Characteristics
2.2. Laboratory-Related Index Levels
2.3. Logistic Regression Analysis
3. Discussion
4. Conclusion
Author Contributions
Funding
Ethics approval and consent to participate
Consent for publication
Availability of data and materials
Acknowledgements
Conflict of Interest
References
- Lee, E.; Lee, Y.Y. Risk factors for the development of post-infectious bronchiolitis obliterans after Mycoplasma pneumoniae pneumonia in the era of increasing macrolide resistance. Respir Med 2020, 175, 106209. [Google Scholar] [CrossRef]
- Colom, A.J.; et al. Risk factors for the development of bronchiolitis obliterans in children with bronchiolitis. Thorax 2006, 61, 503–6. [Google Scholar] [CrossRef]
- Colom, A.J.; et al. Pulmonary function of a paediatric cohort of patients with postinfectious bronchiolitis obliterans. A long term follow-up. Thorax 2015, 70, 169–74. [Google Scholar]
- Gupta, P.; et al. Prolonged mechanical support in children with severe adenoviral infections: a case series and review of the literature. J Intensive Care Med 2011, 26, 267–72. [Google Scholar] [CrossRef]
- Aguerre, V.; et al. Postinfectious bronchiolitis obliterans in children: clinical and pulmonary function findings. Pediatr Pulmonol 2010, 45, 1180–5. [Google Scholar] [CrossRef]
- Li, Y.N.; et al. Post-infectious bronchiolitis obliterans in children: a review of 42 cases. BMC Pediatr 2014, 14, 238. [Google Scholar] [CrossRef] [PubMed]
- Giubergia, V.; et al. Post-infectious bronchiolitis obliterans and mannose-binding lectin insufficiency in Argentinean children. Respirology 2015, 20, 982–6. [Google Scholar] [CrossRef]
- Murtagh, P.; et al. Lower respiratory infections by adenovirus in children. Clinical features and risk factors for bronchiolitis obliterans and mortality. Pediatr Pulmonol 2009, 44, 450–6. [Google Scholar] [CrossRef] [PubMed]
- Smith, K.J.; Fan, L.L. Insights into post-infectious bronchiolitis obliterans in children. Thorax 2006, 61, 462–3. [Google Scholar] [CrossRef] [PubMed]
- Mallol, J.; Aguirre, V.; Espinosa, V. Increased oxidative stress in children with post infectious Bronchiolitis Obliterans. Allergol Immunopathol (Madr) 2011, 39, 253–8. [Google Scholar] [CrossRef] [PubMed]
- Wu, P.Q.; et al. Hypoxemia is an independent predictor of bronchiolitis obliterans following respiratory adenoviral infection in children. Springerplus 2016, 5, 1622. [Google Scholar] [CrossRef] [PubMed]
- Li, L.; et al. Epidemiology, clinical presentation and respiratory sequelae of adenovirus pneumonia in children in Kuala Lumpur, Malaysia. PLoS One 2018, 13, e0205795. [Google Scholar] [CrossRef] [PubMed]
- Foong Ng, K.; et al. Epidemiology of adenovirus respiratory infections among hospitalized children in Seremban, Malaysia. Trans R Soc Trop Med Hyg 2015, 109, 433–9. [Google Scholar] [CrossRef] [PubMed]
- Wang, X.; Tan, X.; Li, Q. The difference in clinical features and prognosis of severe adenoviral pneumonia in children of different ages. J Med Virol 2022, 94, 3303–3311. [Google Scholar] [CrossRef]
- Colom, A.J.; Teper, A.M. Clinical prediction rule to diagnose post-infectious bronchiolitis obliterans in children. Pediatr Pulmonol 2009, 44, 1065–9. [Google Scholar] [CrossRef]
- Wang, X.; et al. Clinical features of post-infectious bronchiolitis obliterans in children undergoing long-term azithromycin treatment. Exp Ther Med 2015, 9, 2379–2383. [Google Scholar] [CrossRef]
- Zhang, H.Y.; et al. [Clinical features of children with severe adenovirus pneumonia and hemophagocytic syndrome: an analysis of 30 cases]. Zhongguo Dang Dai Er Ke Za Zhi 2020, 22, 744–748. [Google Scholar]
- Ions, R.; et al. Case presentation: persistent adenovirus B3 infections associated with bronchiolitis obliterans treated with cidofovir in a child with mosaic tetrasomy 9p. BMC Infect Dis 2018, 18, 529. [Google Scholar] [CrossRef]
- Byun, S.Y.; et al. Bronchiolitis obliterans caused by CMV in a previously healthy Asian infant. Turk J Pediatr 2014, 56, 316–9. [Google Scholar]
- Colom, A.; et al. Authors' response: Long-term lung function in postinfectious bronchiolitis obliterans. Thorax 2015, 70, 793. [Google Scholar] [CrossRef]
- Castro-Rodriguez, J.A. , et al. Adenovirus pneumonia in infants and factors for developing bronchiolitis obliterans: a 5-year follow-up. Pediatr Pulmonol 2006, 41, 947–53. [Google Scholar] [CrossRef] [PubMed]
| Non-OB (n=32) | OB (n=30) | Z/x² | P-value | |
| Age (month) | 20.0(15.1-46.0) | 22.0(10.3-30.5) | -0.898 | 0.369 |
| Sex (Female) | 6(26.1) | 5(24.9) | 0.554 | 0.457 |
| Preterm delivery | 1 | 3 | 0.462 | 0.523 |
| Underlying disease | 4(17.4) | 4(18.2) | 1.000 | |
| Mixed bacterial infection | 18(78.3) | 19(86.4) | 0.699 | |
| Length of hospitalization (d) | 5.0(3.0-7.0) | 7.5(6.0-11.0) | -2.821 | 0.005 |
| Viral typing | ||||
| Untyped | 7(21.7) | 0(0.0) | ||
| HAdV-3 | 14(43.5) | 11(36.4) | 6.682 | 0.030 |
| HAdV-7 | 11(34.8) | 19(63.6) | ||
| Ventilator use | ||||
| None | 17(52.2) | 3(9.1) | ||
| Non-invasive ventilation | 10(30.4) | 18(59.1) | 9.744 | 0.008 |
| Invasive ventilation | 5(17.4) | 9(31.8) | ||
| Duration of ventilator use (h) | 72.5(0.0-113.5) | 159.0(111.5-202.5) | -3.567 | 0.000 |
| Non-OB (n=32) | OB (n=30) | Z/x² | P-value | |
| IgE (KU/L) | 65.0(33.0-122.0) | 55.0(25.4-87.3) | -0.534 | 0.594 |
| IL-6 (pg/mL) | 55.0 (23.0-83.3) | 42.5(20.5-68.9) | 0.568 | 0.570 |
| PaO2 (mm Hg) | 83.0(63.2-110.4) | 74.8(57.6-90.2) | -1.408 | 0.159 |
| Serum ferritin (ng/mL) | 611.5(260.0-989.8) | 885.0(684.0-1645.0) | -2.680 | 0.007 |
| D-dimer (ng/mL) | 2245.0(985.0-3478.0) | 2819.5(976.0-4 624.0) | -0.500 | 0.617 |
| LDH(IU/L) | 630.0(349.0-1425.0) | 638.0(392.8-1133.8) | -0.182 | 0.856 |
| Absolute value of lymphocytes (×109/L) | 2.2(1.7-2.7) | 1.9(1.3-2.8) | 0.466 | 0.642 |
| Factors | SE | Wald X² | P-value | OR | 95%CI |
| Duration of ventilator use | 0.027 | 4.598 | 0.032 | 0.943 | 0.894-0.995 |
| Serum ferritin | 0.003 | 4.369 | 0.037 | 1.006 | 1.000-1.011 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).